HepaLife to develop transdermal pain patch
HepaLife said that its subsidiary, Alliqua BioMedical (Alliqua), recently retained Jeiven Pharmaceutical Consulting (Jeiven) to assist it in this new product development. Through this partnership, Alliqua intends to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.